The company was founded in August 2012 and is a high-tech enterprise focusing on R&D, commercial production and sales of high-end pharmaceutical preparations. The company is committed to the internationalization of pharmaceutical products and provides cost-effective pharmaceutical products to the global market. The company is a chemical pharmaceutical company participating in international competition. The company's main products include high-end generic drugs and CRO services. Corporate honors: The company has won honors such as “Shanghai Enterprise Technology Center”, “Shanghai Science and Technology Little Giant Enterprise”, “1st Guoxin Cup ESG Golden Bull Award Top 50 Technology Leaders”, and the Shanghai High-tech Achievement Transformation Certificate. It has won honors such as “Jiangsu Specialized, Special and New Small and Medium Enterprises”, “Jiangsu Enterprise Technology Center”, and “Advanced Production Safety Unit” in Haimen Development Zone.
Clinical Trials
2
0 active
Approvals
12
Total approvals
Agencies
1
Regulatory bodies
Founded
2012
Completed
1
50.0%
Unknown
1
50.0%
No news articles found
